Tag: ZyCoV-D

Zydus seeks emergency use authorisation for ZyCoV-D

Ahmedabad Others Zydus seeks emergency use authorisation for ZyCoV-D Ahmedabad Mirror July 02, 2021 First Covid vax in India to be tested on 12 to 18 age group; co plans to manufacture 10-12cr doses in yr Ahmedabad-based Zydus Cadila announced on Thursday it has applied to Drug Controller General of…

Continue Reading Zydus seeks emergency use authorisation for ZyCoV-D

Plenty of ‘unwarranted fear mongering’ about Covid virus, pandemic in The Vaccine War

By Word Virus* Vivek Agnihotri is one of India’s most interesting film directors. He is known for his political films that often challenged mainstream narratives. Buddha in a Traffic Jam is about Naxalism. His The Tashkent Files explored controversial theories about the mysterious death of India’s Prime Minister Shri Lal Bahadur…

Continue Reading Plenty of ‘unwarranted fear mongering’ about Covid virus, pandemic in The Vaccine War

2023 Nobel Prize in Medicine (mRNA vaccines)

GS Paper 3  Syllabus: Science and Technology   Source: Nobelprize  Context: The 2023 Nobel Prize in Physiology or Medicine was awarded to Katalin Karikó and Drew Weissman for their research enabling the development of mRNA vaccines against COVID-19. What are RNAs, types of RNAs, and differences with DNAs: See the…

Continue Reading 2023 Nobel Prize in Medicine (mRNA vaccines)

PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines

GOLDEN, Colo., June 28, 2023–(BUSINESS WIRE)–PharmaJet®, a company engineering precision delivery systems that overcome challenges of nucleic acid vaccine delivery, today announced that its Tropis® System is now the exclusive intradermal delivery system for two authorized novel Covid-19 vaccines: This press release features multimedia. View the full release here: www.businesswire.com/news/home/20230628015647/en/…

Continue Reading PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines

Evaluating India’s journey to global vaccine dominance

By Subhasis Banerjee India’s success in the vaccine industry is deep-rooted in the country’s history of achieving excellence, long-term investment over the years and willingness to innovate. The country manufactured vaccines on a global scale and exported them to other countries while also conducting the largest vaccination in the world,…

Continue Reading Evaluating India’s journey to global vaccine dominance

The Game-Changing Needle-Free Covid-19 Vaccine by Zydus!

The government is now receiving ZyCoV-D, a needle-free anti-Covid vaccination, according to a statement released by Zydus Cadila on Wednesday. “The company has started the supplies of its Covid-19 vaccine ZyCoV-D to the government of India against their order from its newly commissioned, state-of-the-art Zydus Vaccine Technology Excellence Centre at…

Continue Reading The Game-Changing Needle-Free Covid-19 Vaccine by Zydus!

The World Immunization Week 2023: A Lot to Catch Up

By Rajib Dasgupta The goal of World Immunization Week is for more children, adults – and their communities – to be protected from vaccine-preventable diseases, allowing them to live happier, healthier lives. The World Immunization Week 2023 (24 to 30 April) is not much of a cheer globally in the…

Continue Reading The World Immunization Week 2023: A Lot to Catch Up

Zydus Needle Free Corona Vaccine Zycov D

According to rajkotupdates.news : zydus needle free corona vaccine zycov d is the world’s first DNA-based jab against COVID-19 and should be given intradermally three times, at days 0, 28, and 56 using PharmaJet needle-free applicator. Phase 3 clinical trial results demonstrated 66.6 percent efficacy against COVID-19 infections among vaccinated…

Continue Reading Zydus Needle Free Corona Vaccine Zycov D

Zydus Begins Supplying the Government with Its Needle-Free Covid Vaccine

Zydus Cadila announced on Wednesday that the federal government has begun receiving the needle-free anti-Covid vaccine ZyCoV-D. “The company has begun supplying the Indian government with its Covid-19 vaccine ZyCoV-D from its newly commissioned, state-of-the-art Zydus Vaccine Technology Excellence Centre in the Zydus Biotech Park in Changodar, Ahmedabad,” the company…

Continue Reading Zydus Begins Supplying the Government with Its Needle-Free Covid Vaccine

Needle-Free Precision Delivery Systems Boost Immune Response of DNA Vaccines: Comprehensive Scientific Literature Review

World Vaccine Congress 2023 presentation, Improved vaccine uptake and clinical responses with PharmaJet Needle-Free Precision Delivery Systems, will highlight results from in-depth review of 26 published scientific manuscripts discussing DNA vaccine administration. Needle-free precision delivery systems (PDS) and traditional methods including electroporation, gene gun, and needle and syringe vaccine delivery…

Continue Reading Needle-Free Precision Delivery Systems Boost Immune Response of DNA Vaccines: Comprehensive Scientific Literature Review

Covid vaccine mission is a lesson for the world

When Covid-19 began in early 2020, most experts predicted India could face disastrous consequences. But the unprecedented and extraordinary response of the government under the personal and constant supervision of Prime Minister (PM) Narendra Modi belied such doomsday predictions. India emerged stronger from the pandemic, setting an example of scientific…

Continue Reading Covid vaccine mission is a lesson for the world

India developed 4 indigenous vaccines in just 2 years: Minister News Jani

New Delhi: Union Minister for Science and Technology Dr. Jitendra Singh on Friday said that under the able guidance and leadership of Prime Minister Shri Narendra Modi, India has developed four indigenous vaccines in just two years. Department of Biotechnology in the Ministry He said that Science and Technology has…

Continue Reading India developed 4 indigenous vaccines in just 2 years: Minister News Jani

Needle-free jet injection of novel COVID-19 DNA vaccine shows promise in animal model

In a recent study posted to the bioRxiv* server, researchers at the United States Army Medical Research Institute of Infectious Diseases evaluated the immunogenicity of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) deoxyribonucleic acid (DNA) vaccine, nCOV-S(JET), in rhesus macaques. A previous evaluation of this coronavirus disease 2019 (COVID-19)…

Continue Reading Needle-free jet injection of novel COVID-19 DNA vaccine shows promise in animal model

DCGI emergency use nod for Covaxin, Corbevax and ZyCoV-D across age groups

The Drug Controller General of India (DCGI) on Tuesday granted emergency use approvals to COVID-19 vaccines Covaxin, Corbevax and ZyCoV-D. While the emergency use authorisation (EUA) was granted to Bharat Biotech’s Covaxin for the age group of 6-12 years, Biological E’s Corbevax bagged the nod…

Continue Reading DCGI emergency use nod for Covaxin, Corbevax and ZyCoV-D across age groups

All you need to know about Covid-19 vaccines available for children

This news brings relief to every family in the country. Now, children above 5 years of age will also be given coronavirus vaccine in the entire country. Till now, children above the age of 12 years were getting the protection of the vaccine, but now children from 5 to 12…

Continue Reading All you need to know about Covid-19 vaccines available for children

Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids

In the wake of schools reporting a spike in coronavirus cases among children, the Drugs Controller General of India (DCGI) has approved the restricted emergency use of three vaccines for different age groups of children — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D. Covaxin has received the…

Continue Reading Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids

What you need to know about the three vaccines approved for children by DCGI

Bharat Biotech COVAXIN – approved for children aged 6-12 years – is made by inactivating the coronavirus – a shot that contains dead parts of SARS-CoV2. Photo : iStock KEY HIGHLIGHTS Biological E’s Cobervax – approved for children aged 5-12 years – is made from a part of the coronavirus,…

Continue Reading What you need to know about the three vaccines approved for children by DCGI

3 months after arrival in Bihar, not a single Covid vaccine shot given

New Delhi: Close to three months since the arrival of the first consignment of ZyCoV-D in Bihar, the vaccine is yet to be included in the nationwide immunisation drive against Covid-19. Data available on the CoWIN dashboard shows that the four vaccines currently part of the vaccination programme are Covaxin,…

Continue Reading 3 months after arrival in Bihar, not a single Covid vaccine shot given

Sensex climbs 236 pts; breadth remains weak

The benchmark indices firmed up further in early afternoon trade. The Nifty regained the 16,500 mark. Realty shares extended recent losses. At 12:20 IST, the barometer index, the S&P BSE Sensex, surged 236.29 points or 0.43% at 55,565.61. The Nifty 50 index added 53.30 points or 0.32% at…

Continue Reading Sensex climbs 236 pts; breadth remains weak